IL-33诱导的活化Th2效应细胞基因表达依赖IL-1RL1单倍型与哮喘状态
研究探讨IL-33对活化Th2效应细胞基因表达的影响是否取决于IL-1RL1单倍型和哮喘状态,发现IL-33反应为哮喘特异性且与高风险单倍型相关,强调其在气道壁细胞中的作用,但因效应Th2细胞稀少,在批量哮喘转录组中检测困难。
要点
- IL-33对Th2细胞的反应具有哮喘特异性,并与IL-1RL1高风险单倍型相关。
- IL-33/IL-1RL1通路与儿童期起病和2型高哮喘强关联,风险等位基因增强通路活性。
- 效应Th2细胞稀少导致批量转录组中IL-33反应检测困难。
核心结论
- IL-33诱导的活化Th2效应细胞基因表达依赖于IL-1RL1单倍型和哮喘状态。
研究设计与样本
- 研究设计与样本量原文未报告。
主要发现
- IL-33对Th2细胞的反应为哮喘特异性,并代表高风险单倍型。
- IL-33反应在气道壁细胞中发挥作用,但因效应Th2细胞稀少在批量转录组中检测困难。
局限性
- 效应Th2细胞稀少导致在批量哮喘转录组中检测IL-33反应具有挑战性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IL-33 response in Th2 cells is specific to asthma and represents a high risk haplotype, highlighting its role in airway wall cells. Yet, its detection is challenging in bulk asthma transcriptomes due to the scarcity of effector Th2 cells. https://bit.ly/3WhuMbo Asthma is a heterogeneous respiratory disease caused by the interaction between environmental and genetic factors [1]. The IL-33 and IL-1RL1 genes are strongly associated with childhood-onset and type-2 high asthma, and the asthma risk alleles amplify interleukin (IL)-33 pathway activity [2]. Environmental factors, such as allergens and viral infections, trigger bronchial epithelial cells to release IL-33, which can activate signalling by binding to the IL-1RL1/IL-1RAcP receptor complex [3], and contribute to hyper-responsiveness, remodelling and chronic type 2 inflammation of the airways [4].
引用
- Saikumar Jayalatha AK, Ketelaar ME, Hesse L, et al. IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status. Eur Respir J. 2024. PMID: 38843913. doi:10.1183/13993003.00005-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。